Medtech
This function is exclusive for Premium subscribers
-
DATABASE (98)
-
ARTICLES (64)
Headquartered in Beijing, Mingtai Capital was founded in 2013. Its total assets under management has surpassed RMB 15 billion. It invests mainly in the following sectors: Internet of things (Iot), advanced manufacturing, culture, media and medtech.
Headquartered in Beijing, Mingtai Capital was founded in 2013. Its total assets under management has surpassed RMB 15 billion. It invests mainly in the following sectors: Internet of things (Iot), advanced manufacturing, culture, media and medtech.
Founded in 1993, WI Harper Group is a venture capital firm investing in early to growth stage companies across the US, Greater China and Asia Pacific. The group has invested in more than 400 companies in the fields of healthcare, biotech, artificial intelligence, robotics, fintech, sustainability and new media. It manages seven venture capital funds with over 100 successful IPO and M&A exits. With three strategic offices in San Francisco, Beijing and Taipei, the group seeks investment opportunities both in the US and Asia.
Founded in 1993, WI Harper Group is a venture capital firm investing in early to growth stage companies across the US, Greater China and Asia Pacific. The group has invested in more than 400 companies in the fields of healthcare, biotech, artificial intelligence, robotics, fintech, sustainability and new media. It manages seven venture capital funds with over 100 successful IPO and M&A exits. With three strategic offices in San Francisco, Beijing and Taipei, the group seeks investment opportunities both in the US and Asia.
Shanghai Zhangjiang Haocheng Venture Capital Co., Ltd. (Zhangjiang Haocheng) was founded in 2007 as a wholly-owned subsidiary of listed real estate developer Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. It has invested RMB 2.5 billion in high-tech startups.
Shanghai Zhangjiang Haocheng Venture Capital Co., Ltd. (Zhangjiang Haocheng) was founded in 2007 as a wholly-owned subsidiary of listed real estate developer Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. It has invested RMB 2.5 billion in high-tech startups.
Proxima Ventures was founded in 2016 in Shanghai. It manages both RMB and US dollar funds, worth around US$150m in total. The firm invests mainly in early-stage startups in the healthcare sector. It has invested in 18 companies and established six innovation centers to incubate medtech startups.
Proxima Ventures was founded in 2016 in Shanghai. It manages both RMB and US dollar funds, worth around US$150m in total. The firm invests mainly in early-stage startups in the healthcare sector. It has invested in 18 companies and established six innovation centers to incubate medtech startups.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Haibang Fund was created in 2011 by Haibang Venture based in Hangzhou. Haibang Fund manages total assets worth US$360m with investments in 60 companies, four of which have gone public. Started by a group of overseas returnees and experienced investors, the VC focuses on startups founded by returnees from overseas.
Haibang Fund was created in 2011 by Haibang Venture based in Hangzhou. Haibang Fund manages total assets worth US$360m with investments in 60 companies, four of which have gone public. Started by a group of overseas returnees and experienced investors, the VC focuses on startups founded by returnees from overseas.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. It has invested in 50 companies and manages RMB2bn worth of total assets. Bioventure invests mostly in the life sciences and bio-pharmaceutical industries, seeking early-stage startups with high growth potential. Bioventure provides post-investment support and services including funding, business operations and management.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. It has invested in 50 companies and manages RMB2bn worth of total assets. Bioventure invests mostly in the life sciences and bio-pharmaceutical industries, seeking early-stage startups with high growth potential. Bioventure provides post-investment support and services including funding, business operations and management.
Renhe Group was founded in Jiangxi Province by Yang Wenlong in 2001. The group, including its flagship listed Renhe Pharmacy, earned total sales revenue of RMB 11.23bn in 2018 with a year-on-year profit growth of 25%. The group comprises 20 subsidiaries dealing in cosmetics, household chemicals, pharmaceutical, medical supplies and equipment.
Renhe Group was founded in Jiangxi Province by Yang Wenlong in 2001. The group, including its flagship listed Renhe Pharmacy, earned total sales revenue of RMB 11.23bn in 2018 with a year-on-year profit growth of 25%. The group comprises 20 subsidiaries dealing in cosmetics, household chemicals, pharmaceutical, medical supplies and equipment.
Lei Ming graduated from Peking University (PKU) with a master's degree in Computer Science. While at university, he was a member of the PKU Sky Network search engine program. In 2000, Lei became one of the seven founding members of Baidu, where he led the search engine design and development team. Lei received his MBA from Stanford Business School in 2003. In 2005, he returned to China and started Kuwo Music, now one of the largest music platforms in China. As an angel investor, Lei focuses on the sectors of AI, consumption, education, medical services and entertainment.
Lei Ming graduated from Peking University (PKU) with a master's degree in Computer Science. While at university, he was a member of the PKU Sky Network search engine program. In 2000, Lei became one of the seven founding members of Baidu, where he led the search engine design and development team. Lei received his MBA from Stanford Business School in 2003. In 2005, he returned to China and started Kuwo Music, now one of the largest music platforms in China. As an angel investor, Lei focuses on the sectors of AI, consumption, education, medical services and entertainment.
Shangshi Capital was founded and headquartered in Beijing in 2014. It has branch offices in Shenzhen and San Francisco. The firm manages two US dollar funds and three RMB funds, totaling over RMB 1.5bn. It has invested in over 60 startups at home and abroad, mainly in digital healthcare, consumer goods, IoT and enterprise tech.
Shangshi Capital was founded and headquartered in Beijing in 2014. It has branch offices in Shenzhen and San Francisco. The firm manages two US dollar funds and three RMB funds, totaling over RMB 1.5bn. It has invested in over 60 startups at home and abroad, mainly in digital healthcare, consumer goods, IoT and enterprise tech.
Founded in 2005, Fortune Link focuses on private equity investment. Its founder, Kan Zhidong was also the founder of Shenzhen Capital Group, one of the first few venture capitalists in China. As at March 2018, it had set up a number of funds and managed over 20 investment teams.With over RMB 30bn worth of assets under its management, Fortune Link mainly invests in sectors including TMT, environmental protection, advanced material, healthcare, high tech industries, culture and media.
Founded in 2005, Fortune Link focuses on private equity investment. Its founder, Kan Zhidong was also the founder of Shenzhen Capital Group, one of the first few venture capitalists in China. As at March 2018, it had set up a number of funds and managed over 20 investment teams.With over RMB 30bn worth of assets under its management, Fortune Link mainly invests in sectors including TMT, environmental protection, advanced material, healthcare, high tech industries, culture and media.
GF Qianhe is an equity investment company launched by GF Securities in May 2012. Incorporated as Guangfa Qianhe Investments Co Ltd, with a registered capital of RMB 500m, the company was one of the earliest alternative investment companies to gain approval from the Securities Commission of China. As of late 2018, GF Qianhe has invested in 86 equity-related projects, among which four have gone public. By the end of 2014, its total investment value reached almost RMB 2bn and revenues of over RMB 340m.
GF Qianhe is an equity investment company launched by GF Securities in May 2012. Incorporated as Guangfa Qianhe Investments Co Ltd, with a registered capital of RMB 500m, the company was one of the earliest alternative investment companies to gain approval from the Securities Commission of China. As of late 2018, GF Qianhe has invested in 86 equity-related projects, among which four have gone public. By the end of 2014, its total investment value reached almost RMB 2bn and revenues of over RMB 340m.
CAS Star was established in September 2013 in Xi’an by several VC firms and the Xi’an Institute of Optics and Precision Mechanics of Chinese Academy of Sciences. The high-tech startup incubator has also set up a RMB 5.2bn Xike Angel fund to specialize in the commercialization of the high-tech research projects. To date, Xike Angel has a portfolio of more than 230 startups with a total value of RMB 20bn.
CAS Star was established in September 2013 in Xi’an by several VC firms and the Xi’an Institute of Optics and Precision Mechanics of Chinese Academy of Sciences. The high-tech startup incubator has also set up a RMB 5.2bn Xike Angel fund to specialize in the commercialization of the high-tech research projects. To date, Xike Angel has a portfolio of more than 230 startups with a total value of RMB 20bn.
Founded by former IDG Capital partner Zhang Suyang in May 2016, the Shanghai-based VC firm invests mainly in early-stage startups working on tech innovations and healthcare. Total assets under management exceed RMB 2.2bn.
Founded by former IDG Capital partner Zhang Suyang in May 2016, the Shanghai-based VC firm invests mainly in early-stage startups working on tech innovations and healthcare. Total assets under management exceed RMB 2.2bn.
Based in Shanghai, Sharewin Investment was founded in 2005. In 2010, the company changed its focus from PE to VC. It invests mainly in the healthcare, TMT, new material, advanced manufacturing, arts and entertainment and consumer products sectors.
Based in Shanghai, Sharewin Investment was founded in 2005. In 2010, the company changed its focus from PE to VC. It invests mainly in the healthcare, TMT, new material, advanced manufacturing, arts and entertainment and consumer products sectors.
SWITCH Singapore 2021: How to harness the power of the deep tech ecosystem
Investor Jason Illian of Koch Disruptive Technologies talks talent, scaling for deep tech startups, and why longer gestation periods and mid-course pivots don’t have to be deal breakers
SWITCH Singapore 2021: Benefits and challenges of AI applications in healthcare
Medical experts and healthcare startups agree AI can contribute more to healthcare beyond improving diagnosis and personalized treatment, but hurdles still remain
Sequoia China Seed Fund: Growing an era of deep-tech startups
Managing Partner Neil Shen wants to help deep-tech and enterprise tech startups get investments more easily, across quantum computing, semiconductors, synthetic biology and more
South Summit 2021: Martin Varavsky, Leandro Sigman on post-Covid healthcare trends
Serial entrepreneur Martin Varavsky and Insud Pharma Chairman Leandro Sigman share their thoughts and projections on the future of health tech
Intudo Ventures: Grooming returning overseas talent for an Indonesia-only bet
Combining the experience and networks of foreign-educated Indonesians with local distribution channels, Intudo’s hyperlocal strategy has attracted $200m in managed assets
ARTICARES: Personalized, more affordable arm rehab therapy at home
Using adaptive AI, its H-Man robot works like an occupational therapist, assessing patient’s performance and adjusting the complexity of training tasks in real time
Sequoia Capital China holds steady with investments in healthcare, biotech and green economy
China’s most active investor increases bets on sectors beyond the consumer internet and edtech recently hurt by regulatory clampdown
New sectors, strategies come into play as investors respond to China's Big Tech curbs
Amid the crackdown on China’s tech giants, some investors are sussing out less risky sectors, while heavyweights like BlackRock and Fidelity stay in for the long haul
Aimentia: Pioneering mental health AI SaaS seeks to improve diagnosis as demand surges
Barcelona-based Aimentia supports the oft-overlooked mental health segment through digitalization and analytics, going beyond therapy platforms
Zoundream: Deciphering and mining the data in baby cries
The world’s first algorithm to translate baby cries into actionable insights for parents and hospitals seeks to boost early detection of pathologies and developmental disorders
Nuuk, the cooler box poised to disrupt cold chain logistics
Barcelona-based startup Groenlandia Tech has developed a smart cooler box to track and monitor biological samples, providing an extra layer of security and control during transport
Vence: Virtual fencing for sustainable livestock rearing
The startup uses GPS and AI algorithms to create virtual fences that work with animal collars for more efficient management of livestock and grasslands
TreeFrog Therapeutics: Mimicking how stem cells grow in the human body
The French biotech’s proprietory technology to cultivate pluripotent stem cells in a 3D environment can be scaled to mass-produce high-quality cells to treat diseases such as Parkinson’s
Therapixel: Using AI to improve breast cancer detection
Therapixel is raising €15m for commercial expansion of its AI-powered MammoScreen that gives accurate breast cancer screening results within minutes
HumanITcare: Covid-19 spurs demand for telemedicine across Spain and beyond
The startup’s revenue is expected to exceed €10m by 2024 due to rapid digital transformation of healthcare services and a growing market for AI-powered medtechs
POPULAR DATABASE
